Trends in Outpatient Visits with Benzodiazepines among US Adults With and Without Bronchitis or Chronic Obstructive Pulmonary Disease from 1999 to 2010

References

• Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults–United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61(46):938–943.
   PubMedGoogle Scholar
• Ford ES, Mannino DM, Wheaton AG et al. Trends in the Prevalence of Obstructive and Restrictive Lung Function among Adults in the United States: Findings from the National Health and Nutrition Examination Survey from 1988–1994 to 2007–2010. Chest 2013; 143(5):1395–1406.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Rodriguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc 2011; 8(4):363–367.
   PubMedGoogle Scholar
• Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. J Psychosom Res 2007; 63(5):551–565.
   PubMed Web of Science ®Google Scholar
• Budhiraja R, Parthasarathy S, Budhiraja P et al. Insomnia in patients with COPD. Sleep 2012; 35(3):369–375.
   PubMed Web of Science ®Google Scholar
• Vozoris NT, Fischer HD, Wang X et al. Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging 2013; 30(3):183–192.
   PubMed Web of Science ®Google Scholar
• Vozoris NT, Fischer HD, Wang X et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 2014; 44(2):332–340.
   PubMed Web of Science ®Google Scholar
• Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ 2014; 348(g445).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Ambulatory Health Care Data. 2013. Available from: http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm.
   Google Scholar
• Hing E, Hall MJ, Ashman JJ, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 outpatient department summary. Natl Health Stat Report 2010; 28:1–32.
   PubMedGoogle Scholar
• Burt CW, Hing E. Making patient-level estimates from medical encounter records using a multiplicity estimator. Stat Med 2007; 26(8):1762–1774.
   PubMed Web of Science ®Google Scholar
• Catchlove RF, Kafer ER. The effects of diazepam on respiration in patients with obstructive pulmonary disease. Anesthesiology 1971; 34(1):14–18.
   PubMed Web of Science ®Google Scholar
• Clark TJ, Collins JV, Tong D. Respiratory depression caused by nitrazepam in patients with respiratory failure. Lancet 1971; 2(7727):737–738.
   PubMed Web of Science ®Google Scholar
• Kronenberg RS, Cosio MG, Stevenson JE, Drage CW. Letter: The use of oral diazepam in patients with obstructive lung disease and hypercapnia. Ann Intern Med 1975; 83(1):83–84.
   PubMed Web of Science ®Google Scholar
• Model DG. Nitrazepam induced respiratory depression in chronic obstructive lung disease. Br J Dis Chest 1973; 67(2):128–130.
   PubMedGoogle Scholar
• Model DG, Berry DJ. Effects of chlordiazepoxide in respiratory failure due to chronic bronchitis. Lancet 1974; 2(7885):869–870.
   PubMed Web of Science ®Google Scholar
• Gaddie J, Legge JS, Palmer KN et al. Effect of nitrazepam in chronic obstructive bronchitis. Br Med J 1972; 2(5815):688–689.
   PubMed Web of Science ®Google Scholar
• Denaut M, Yernault JC, De CA. Double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with chronic obstructive lung disease. Curr Med Res Opin 1975; 2(10):611–615.
   Google Scholar
• Geddes DM, Rudolf M, Saunders KB. Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. Thorax 1976; 31(5):548–551.
   PubMed Web of Science ®Google Scholar
• Man GC, Hsu K, Sproule BJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 1986; 90(6):832–836.
   PubMed Web of Science ®Google Scholar
• Murciano D, Aubier M, Palacios S, Pariente R. Comparison of zolpidem (Z), triazolam (T), and flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD). Chest 1990; 97(3 Suppl):51S–52S.
   PubMed Web of Science ®Google Scholar
• Murciano D, Armengaud MH, Cramer PH et al. Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir J 1993; 6(5):625–629.
   PubMed Web of Science ®Google Scholar
• Roggla G, Moser B, Roggla M. Effect of temazepam on ventilatory response at moderate altitude. BMJ 2000; 320(7226):56.
   PubMed Web of Science ®Google Scholar
• Beaupre A, Soucy R, Phillips R, Bourgouin J. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease. Respiration 1988; 54(4):235–240.
   PubMed Web of Science ®Google Scholar
• Cummiskey J, Guilleminault C, Del RG, Silvestri R. The effects of flurazepam on sleep studies in patients with chronic obstructive pulmonary disease. Chest 1983; 84(2):143–147.
   PubMed Web of Science ®Google Scholar
• Timms RM, Dawson A, Hajdukovic RM, Mitler MM. Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease. Arch Intern Med 1988; 148(10):2159–2163.
   PubMed Web of Science ®Google Scholar
• Midgren B, Hansson L, Skeidsvoll H, Elmqvist D. The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD. Chest 1989; 95(4):765–768.
   PubMed Web of Science ®Google Scholar
• Stege G, Heijdra YF, van den Elshout FJ et al. Temazepam 10mg does not affect breathing and gas exchange in patients with severe normocapnic COPD. Respir Med 2010; 104(4):518–524.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6):932–946.
   PubMed Web of Science ®Google Scholar
• Marciniuk DD, Goodridge D, Hernandez P et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2011; 18(2):69–78.
   PubMed Web of Science ®Google Scholar
• Swartz M, Landerman R, George LK et al. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. Am J Public Health 1991; 81(5):592–596.
   PubMed Web of Science ®Google Scholar
• Gleason PP, Schulz R, Smith NL et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13(4):243–250.
   PubMed Web of Science ®Google Scholar